ATE362783T1 - Verwendung von dapson als neuroprotektor bei zerebralinfarkt - Google Patents

Verwendung von dapson als neuroprotektor bei zerebralinfarkt

Info

Publication number
ATE362783T1
ATE362783T1 AT04721040T AT04721040T ATE362783T1 AT E362783 T1 ATE362783 T1 AT E362783T1 AT 04721040 T AT04721040 T AT 04721040T AT 04721040 T AT04721040 T AT 04721040T AT E362783 T1 ATE362783 T1 AT E362783T1
Authority
AT
Austria
Prior art keywords
dapsone
neuroprotector
cerebral infarction
stroke
brain stroke
Prior art date
Application number
AT04721040T
Other languages
English (en)
Inventor
Castaneda Luis Camilo Rios
Martinez Marina Altagracia
Kawachi Juan Nader
Jinich J Kravzov
Original Assignee
Univ Autonoma Metropolitana
Inst Nacional De Neurologia Y
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34075071&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE362783(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Autonoma Metropolitana, Inst Nacional De Neurologia Y filed Critical Univ Autonoma Metropolitana
Application granted granted Critical
Publication of ATE362783T1 publication Critical patent/ATE362783T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04721040T 2003-07-22 2004-03-16 Verwendung von dapson als neuroprotektor bei zerebralinfarkt ATE362783T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA03006549A MXPA03006549A (es) 2003-07-22 2003-07-22 Uso de la dapsona como neuroprotector en el infarto cerebral.

Publications (1)

Publication Number Publication Date
ATE362783T1 true ATE362783T1 (de) 2007-06-15

Family

ID=34075071

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04721040T ATE362783T1 (de) 2003-07-22 2004-03-16 Verwendung von dapson als neuroprotektor bei zerebralinfarkt

Country Status (14)

Country Link
US (1) US8268893B2 (de)
EP (1) EP1655055B1 (de)
JP (1) JP5452844B2 (de)
CN (1) CN100500246C (de)
AT (1) ATE362783T1 (de)
BR (1) BRPI0412212A (de)
CA (1) CA2533181C (de)
DE (1) DE602004006633T2 (de)
EA (1) EA012174B1 (de)
EC (1) ECSP066316A (de)
ES (1) ES2287713T3 (de)
MX (1) MXPA03006549A (de)
PT (1) PT1655055E (de)
WO (1) WO2005007239A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009004635A (es) * 2009-04-29 2010-10-29 Univ Autonoma Metropolitana Formas farmaceúticas solubles de la n,n´-diamino-difenilsulfona para su uso óptimo en el tratamiento de diversas enfermedades.
KR101875705B1 (ko) * 2011-12-07 2018-07-06 삼성전자주식회사 디아미노디페닐술폰을 포함하는 근육 소모 관련 질환의 예방 또는 치료용 약학적 조성물
CN104177610A (zh) * 2013-05-27 2014-12-03 韩文毅 一种非线性的聚合物及其制备和用途
CN104177611A (zh) * 2013-05-27 2014-12-03 韩文毅 一种非线性的聚合物及其制备和用途
CN104069091A (zh) * 2014-07-09 2014-10-01 崔德华 氨苯砜在保护血脑屏障完整性中的应用
KR20160047318A (ko) * 2014-10-22 2016-05-02 삼성전자주식회사 다프손을 포함하는, 개체의 부위에서 혈관신생을 자극시키기 위한 조성물 및 그의 용도
KR20200107899A (ko) * 2019-11-16 2020-09-16 이종훈 알츠하이머병 혹은 뇌졸중의 뉴로인플라마섬의 치료제로서 디디에스 혹은 그 유도체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532219A (en) * 1991-04-23 1996-07-02 The University Of British Columbia Dapsone and promin for the treatment of dementia
SK662001A3 (en) * 1998-07-15 2001-10-08 Hassan Jomaa Phosphorous organic compounds and their use
GB2362101A (en) * 2000-05-12 2001-11-14 Astrazeneca Ab Treatment of chronic obstructive pulmonary disease

Also Published As

Publication number Publication date
CA2533181A1 (en) 2005-01-27
JP2006528175A (ja) 2006-12-14
EA012174B1 (ru) 2009-08-28
EA200600272A1 (ru) 2006-10-27
ECSP066316A (es) 2006-10-25
CN100500246C (zh) 2009-06-17
EP1655055A1 (de) 2006-05-10
US20100063159A1 (en) 2010-03-11
WO2005007239A1 (es) 2005-01-27
DE602004006633D1 (de) 2007-07-05
HK1098086A1 (zh) 2007-07-13
CA2533181C (en) 2012-08-07
DE602004006633T2 (de) 2008-01-31
PT1655055E (pt) 2007-08-31
CN1852749A (zh) 2006-10-25
BRPI0412212A (pt) 2006-08-22
EP1655055B1 (de) 2007-05-23
WO2005007239B1 (es) 2005-05-06
MXPA03006549A (es) 2004-03-18
US8268893B2 (en) 2012-09-18
JP5452844B2 (ja) 2014-03-26
ES2287713T3 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
ATE535236T1 (de) Therapeutische strategien für die prävention und behandlung der alzheimer-krankheit
DK1688488T3 (da) Bispecifikt antistof som erstatning for faktor III
EP1463531A4 (de) Verfahren zur hemmung okularer vorgänge
PT1446387E (pt) Derivados de aril-1,4-pirazina substituídos
PL1765388T3 (pl) Terapia skojarzona do zapobiegania chorobie Alzheimera lub leczenia tej choroby oraz zestaw do tego celu
EA200300027A1 (ru) Способ лечения сердечно-сосудистых заболеваний
DE602006008643D1 (de) Ophthalmische Zusammensetzungen von parasympathischen Stimulantia und Entzündungshemmer zur Verwendung bei der Behandlung von Presbyopie
ATE355293T1 (de) Substituierte 7-aza-(2.2.1)bicycloheptane für die behandlung von krankheiten
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
ATE427114T1 (de) Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen
ATE345792T1 (de) Verwendung von mit azetidinon substituierten derivaten bei der behandlung der alzheimer- krankheit
DE602004029034D1 (de) Replikin-peptide und anwendungen
WO2001058476A3 (en) Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity
DE602004006633D1 (de) Verwendung von dapson als neuroprotektor bei zerebralinfarkt
ATE424825T1 (de) Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
ATE556707T1 (de) Phosphodiesesterase 4 inhibitoren zur behandlung eines kognitiven defizits
ATE552251T1 (de) Thiophen- und furanverbindungen
PL376056A1 (en) 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases
MXPA05002418A (es) Derivados de 1,4-pirazina sustituidos.
PL1979521T3 (pl) Nowy sposób impregnowania powierzchni tekstylnych
DE602004026597D1 (de) Behandlung von alzheimer-krankheit und verwandten zuständen
DE60201440D1 (de) Aryl-8-azabicyclo[3.2.1]octanes für die behandlung von depression
DE60228988D1 (de) Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen
GB0110369D0 (en) Articulated bicycle seat
ZA200609220B (en) Method of treating dry eye disorders and uveitis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties